Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 199713
Gene Symbol: NLRP7
NLRP7
0.100 Biomarker group HPO
Entrez Id: 2492
Gene Symbol: FSHR
FSHR
0.100 Biomarker group HPO
Entrez Id: 3655
Gene Symbol: ITGA6
ITGA6
0.100 Biomarker group HPO
Entrez Id: 10157
Gene Symbol: AASS
AASS
0.100 Biomarker group HPO
Entrez Id: 9968
Gene Symbol: MED12
MED12
0.100 Biomarker group HPO
Entrez Id: 7450
Gene Symbol: VWF
VWF
0.100 Biomarker group HPO
Entrez Id: 4763
Gene Symbol: NF1
NF1
0.100 CausalMutation group CLINVAR
Entrez Id: 5339
Gene Symbol: PLEC
PLEC
0.100 Biomarker group HPO
Entrez Id: 3691
Gene Symbol: ITGB4
ITGB4
0.100 Biomarker group HPO
Entrez Id: 2245
Gene Symbol: FGD1
FGD1
0.300 Biomarker group CTD_human A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in an Italian family with faciogenital dysplasia (Aarskog-Scott syndrome). 10930571 2000
Entrez Id: 7490
Gene Symbol: WT1
WT1
0.040 GeneticVariation group BEFREE A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. 8381368 1993
Entrez Id: 7490
Gene Symbol: WT1
WT1
0.040 GeneticVariation group BEFREE All four del(11)(p13) cases presented with WAGR, a complex syndrome associated with a predisposition to Wilms' tumor (WT), aniridia (A), genitourinary abnormalities (G), and mental retardation (R). 2570677 1989
Entrez Id: 100528024
Gene Symbol: DEL11P13
DEL11P13
0.010 GeneticVariation group BEFREE All four del(11)(p13) cases presented with WAGR, a complex syndrome associated with a predisposition to Wilms' tumor (WT), aniridia (A), genitourinary abnormalities (G), and mental retardation (R). 2570677 1989
Entrez Id: 5080
Gene Symbol: PAX6
PAX6
0.010 GeneticVariation group BEFREE All four del(11)(p13) cases presented with WAGR, a complex syndrome associated with a predisposition to Wilms' tumor (WT), aniridia (A), genitourinary abnormalities (G), and mental retardation (R). 2570677 1989
Entrez Id: 92579
Gene Symbol: G6PC3
G6PC3
0.020 Biomarker group BEFREE All patients had failure to thrive and some of the classic syndromic features of G6PC3 deficiency, including cardiac abnormalities and visibility of superficial veins in all, endocrinologic problems in PI and PIII, and urogenital abnormalities in PII. 26479985 2015
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
0.010 GeneticVariation group BEFREE Antley-Bixler syndrome (ABS) represents a group of heterogeneous disorders characterized by skeletal, cardiac, and urogenital abnormalities that have frequently been associated with mutations in fibroblast growth factor receptor 2 or cytochrome P450 reductase genes. 21705796 2011
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.010 GeneticVariation group BEFREE Antley-Bixler syndrome (ABS) represents a group of heterogeneous disorders characterized by skeletal, cardiac, and urogenital abnormalities that have frequently been associated with mutations in fibroblast growth factor receptor 2 or cytochrome P450 reductase genes. 21705796 2011
Entrez Id: 582
Gene Symbol: BBS1
BBS1
0.010 Biomarker group BEFREE Comparing BBS1 versus chaperonin-like genes phenotypes we found more severe clinical features in the second group, since they displayed higher prevalence of all primary features, remarkable being the frequency of cognitive impairment (75%) in BBS12 and urogenital anomalies (83%) in patients with BBS10. 26082521 2015
Entrez Id: 166379
Gene Symbol: BBS12
BBS12
0.010 GeneticVariation group BEFREE Comparing BBS1 versus chaperonin-like genes phenotypes we found more severe clinical features in the second group, since they displayed higher prevalence of all primary features, remarkable being the frequency of cognitive impairment (75%) in BBS12 and urogenital anomalies (83%) in patients with BBS10. 26082521 2015
Entrez Id: 79738
Gene Symbol: BBS10
BBS10
0.010 GeneticVariation group BEFREE Comparing BBS1 versus chaperonin-like genes phenotypes we found more severe clinical features in the second group, since they displayed higher prevalence of all primary features, remarkable being the frequency of cognitive impairment (75%) in BBS12 and urogenital anomalies (83%) in patients with BBS10. 26082521 2015
Entrez Id: 815
Gene Symbol: CAMK2A
CAMK2A
0.100 CausalMutation group CLINVAR De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability. 29100089 2017
Entrez Id: 22884
Gene Symbol: WDR37
WDR37
0.300 Biomarker group GENOMICS_ENGLAND De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia. 31327508 2019
Entrez Id: 10297
Gene Symbol: APC2
APC2
0.300 Biomarker group GENOMICS_ENGLAND Directional neuronal migration is impaired in mice lacking adenomatous polyposis coli 2. 22573669 2012
Entrez Id: 92579
Gene Symbol: G6PC3
G6PC3
0.020 Biomarker group BEFREE Glucose-6-phosphatase catalytic subunit 3 (G6PC3) deficiency is a newly described syndromic type of severe congenital neutropenia, associated with multiple organ abnormalities including facial, cardiac, and urogenital abnormalities, and increased visibility of superficial veins. 23018568 2013
Entrez Id: 745
Gene Symbol: MYRF
MYRF
0.010 GeneticVariation group BEFREE Heterozygous variants in MYRF should be considered in patients with variants of Scimitar syndrome and urogenital anomalies. 29446546 2018